PATHOGENOMICS Constituent Assembly 13-15 October 2004 Berlin, Germany

0 comments

file time: 2008-02-16

filetype:ppt

Click Here To Download...

>  
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

PATHOGENOMICS 
Constituent Assembly 
 
13-15 October 2004   
Berlin, Germany 

Sixth Framework  
Programme 

European Commission

Research DG

 
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

The EU00 framework programme (FP) is the major tool to support the research in Europe. 
 

The FP6 2002-2006 is the major tool to support the creation of the

European Research Area 00ERA 
 

 
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

EUROPEAN RESEARCH AREA 

Creation of a European Internal market for Research to: 

Avoid fragmentation Encourage cooperation and coordination Facilitate integration  
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

Coordination of Research in FP6 

Policy level

open method of coordination mapping, benchmarking, score boards  

Programme level

ERA-NET Article 169  

Project level

New Instruments Traditional Instruments  
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

 
To step up the cooperation and coordination of national or regional research activities through networking of national/regional programmes including their mutual opening and the development and implementation of joint activities.  
 
 
00rogrammes00/font> should be understood as entire research and innovation programmes, or parts of such programmes, or similar initiatives. 

 
ERA-NET-SCHEME 
Objectives  
 
 
 

 
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

ERA-NET partnership: a key to success 

WHO? 
 
 

Partners are programme owners/managers acting on behalf of national/regional public authorities : 
 

such as ministries, funding agencies, research councils,

in some cases programme management organisations or coordination bodies; 

 
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 
 
 
 
 

ERA-NET may include the following activities to foster

coordination and cooperation between programmes: 

1 - Systematic exchange of information & best practices

2 - Common strategic issues

3 - Development of joint activities

4 - Implementation of transnational research activities

      
 
 

Activities 

A step by step approach00but ambitious

 
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

Information exchange between programme managers on:

(possible examples) 

Actual running projects in the respective programmes National or regional research priorities Existing evaluation practices Programme management practices  

1 - Systematic exchange of

information and best practices

 
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

2 - Common strategic issues 
 

Identification and analysis of:

(possible examples) 

Research activities that could lead to multinational schemes between ERA-NET partners Practical networking activities and mutual opening mechanisms Administrative or legal barriers that hinder transnational cooperation New opportunities and gaps in research and stimulation of new interdisciplinary work Common evaluation systems  
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

3 - Development of joint activities  
 

Concrete joint activities could cover: (possible examples)

Development of multinational evaluation procedures; Schemes for joint training activities; Mutual opening of facilities or laboratories; Common programme monitoring and evaluation; Personnel exchange only at programme manager level; Specific co-operation agreements or arrangements; Action plan to implement a joint strategy00/b>  
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

4 - Implementation of

transnational research activities 

Implementation of transnational research activities could include:

(possible examples) 

Common or joint calls for proposals; Setting up of a joint work programme; Transnational evaluation and dissemination; Funding of research activities based on a joint programme of transnational research activities00/b>  
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

Instrument: Coordination Actions 

  

All activities  covering the indicated steps related to networking of national or regional programmes are eligible for financial support.  

No research activities will be financed by ERA-NET (CA) .  
 
 

PATHOGENOMICS funding : 3.000.000 M00/b>  
Duration:  5 years  
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

Open call for proposals (single step)  

Total indicative budget:  148 M00/b> ( 2002- 2006) 
 
 

Last cut-off dates: 02.03.2005 and 04.10.2005

Instrument: ONLY CA 
 
 
 

Calls and Budget

 
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

Parts of contract 

Core-contract

Standard text completed with project data (+ special clauses) 

Annex I

The 00escription of Work00/font> 

Annex II

General conditions (standard text) 

Annex IV - Form A

Accession to the contract 

Annex V - Form B

Accession of new legal entities to the contract 

Annex VI - Form C

Financial statement per activity (to be filled periodically by each                   contractor)

 
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

Accession to contract 

Coordinator and Commission sign contract; other contractors00 written consents are collected by the coordinator and sent to the Commission within two months (A-form).  

    Note: advance payment may not be distributed before the minimum number of 00ther00contractors (2 for ERA-NET CAs)  have returned the A-form 

 
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

Contractual dates 

Entering into force of contract: date of signature by Commission 17/08/2004  
Start date of project: date defined in contract : 01/09/2004  
End date of project: after duration of project : 1/09/2009  
End date of contract: end of contractual agreements (up to 5 years from the end of the project).  
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 
 

without additional funding with implicit agreement of the Commission within 6 weeks at the request of the coordinator, deemed to act on behalf of the consortium  
with additional funding supplementary proposal at any future ERA-NET cut-off dates (March or October 2005) same funding limits as new proposals  

Change/Addition of contractors 

 
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

Objectives for Coordination of national and regional programmes in FP7 

Maintain the type of participants in ERA-NET (programme owners);  
Underline the need for 00mbitious goals00to achieve more 00ard00coordination of programmes;  
00eepen00the existing ERA-NETs (activities, countries, regions);    
Activities in-between networking of programmes and Art. 169 (flexible instrument) ERA-NET-Plus00/i>  
 
 

Support for the coordination of activities 

00RA-NET00/b> 

Pathogenomics,13-15 October 2004,Berlin

C.Stoffels 

Infopack:  http://www.cordis.lu/fp6/calls.cfm 

NCPs:   http://www.cordis.lu/fp6/ncp.htm 

Website:   

   download PATHOGENOMICS Constituent Assembly 13-15 October 2004 Berlin, Germany